Isoetharine Mesylate

CHEMBL1201153 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
335.4 g/mol
LogP
Phase
4

This mesylate salt of isoetharine is a short-acting beta-agonist bronchodilator previously used in nebulizer solutions for asthma and bronchospasm relief. It stimulates beta-2 adrenergic receptors to relax airway smooth muscle. Newer selective and longer-acting beta-agonists have largely replaced it in clinical practice.

Peso molecular

335,4200 g/mol

TPSA

135,00 Ų

Mecanismo de acción

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.CS(=O)(=O)O

InChI

InChI=1S/C13H21NO3.CH4O3S/c1-4-10(14-8(2)3)13(17)9-5-6-11(15)12(16)7-9;1-5(2,3)4/h5-8,10,13-17H,4H2,1-3H3;1H3,(H,2,3,4)

Molecular Formula

C14H25NO6S

HBD / HBA

5 / 7

Enlaces Rotables

5

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This mesylate salt of isoetharine is a short-acting beta-agonist bronchodilator previously used in nebulizer solutions for asthma and bronchospasm relief. It stimulates beta-2 adrenergic receptors to relax airway smooth muscle. Newer selective and longer-acting beta-agonists have largely replaced it in clinical practice.

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Yes, Isoetharine Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201153. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23702. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.